1. Home
  2. VKTX
  3. VKTX News

Latest Viking Therapeutics Inc. (VKTX) News on January 22, 2025

The race for the next Ozempic is on
VKTX

Quartz

a day ago

The race for the next Ozempic is on

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
VKTX

Zacks

2 days ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week
VKTX

Insider Monkey

2 days ago

Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
VKTX

Motley Fool

5 days ago

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential
VKTX

Insider Monkey

5 days ago

Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down
VKTX

Zacks

7 days ago

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
VKTX

BioPharma Dive

8 days ago

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
VKTX

Motley Fool

8 days ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know
VKTX

Zacks

9 days ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
VKTX

Investor's Business Daily

13 days ago

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment
VKTX

Clinical Trials Arena

13 days ago

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
VKTX

Zacks

13 days ago

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

3 Mid-Cap Stocks That Could Take Off in 2025
VKTX

Motley Fool

13 days ago

3 Mid-Cap Stocks That Could Take Off in 2025

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
VKTX

PR Newswire

14 days ago

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know
VKTX

Zacks

16 days ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
VKTX

PR Newswire

16 days ago

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Why Viking Therapeutics Stock Plummeted by 24% in December
VKTX

Motley Fool

18 days ago

Why Viking Therapeutics Stock Plummeted by 24% in December

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
VKTX

Zacks

19 days ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

From Davids to Goliaths: the GLP-1RA gold rush
VKTX

Pharmaceutical Technology

19 days ago

From Davids to Goliaths: the GLP-1RA gold rush

Should You Buy the Dip on This High-Flying Stock?
VKTX

Motley Fool

19 days ago

Should You Buy the Dip on This High-Flying Stock?

VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?
VKTX

Zacks

20 days ago

VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?

Why Is Viking Therapeutics, Inc. (VKTX) Among the Best Multibagger Stocks to Buy Right Now?
VKTX

Insider Monkey

21 days ago

Why Is Viking Therapeutics, Inc. (VKTX) Among the Best Multibagger Stocks to Buy Right Now?

Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors
VKTX

Zacks

22 days ago

Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors

3 Stocks That Could Be Monster Winners in 2025
VKTX

Motley Fool

24 days ago

3 Stocks That Could Be Monster Winners in 2025

Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know

Will Viking Therapeutics, Inc. (VKTX) Make You Rich In 2025?
VKTX

Insider Monkey

a month ago

Will Viking Therapeutics, Inc. (VKTX) Make You Rich In 2025?

3 biggest catalysts expected for healthcare in 2025
VKTX

Yahoo Finance Video

a month ago

3 biggest catalysts expected for healthcare in 2025

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Biotech Stock in 2024?
VKTX

Insider Monkey

a month ago

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Biotech Stock in 2024?

Hot Obesity Drug Market Will Keep Investors Gripped Next Year
VKTX

Bloomberg

a month ago

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
VKTX

Motley Fool

a month ago

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

My Top 10 Stocks to Buy for 2025
VKTX

Motley Fool

a month ago

My Top 10 Stocks to Buy for 2025

Why Viking Therapeutics Tumbled by More Than 10% This Week
VKTX

Motley Fool

a month ago

Why Viking Therapeutics Tumbled by More Than 10% This Week

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.
VKTX

Investor's Business Daily

a month ago

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
VKTX

Motley Fool

a month ago

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

VKTX

MT Newswires

a month ago

Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.
VKTX

Investor's Business Daily

a month ago

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug
VKTX

Zacks

a month ago

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth
VKTX

Simply Wall St.

a month ago

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth

Here's Why VKTX Stock Plummeted 18% on Wednesday
VKTX

Zacks

a month ago

Here's Why VKTX Stock Plummeted 18% on Wednesday

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else
VKTX

Investor's Business Daily

a month ago

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today?
VKTX

Insider Monkey

a month ago

Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today?

What's Going On With Viking Therapeutics Stock On Wednesday?
VKTX

Benzinga

a month ago

What's Going On With Viking Therapeutics Stock On Wednesday?

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.
VKTX

Barrons.com

a month ago

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
VKTX

Insider Monkey

a month ago

Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
VKTX

Investor's Business Daily

a month ago

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
VKTX

Motley Fool

a month ago

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
VKTX

Motley Fool

a month ago

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know

Warning: This Skyrocketing Stock Has a Hidden Risk
VKTX

Motley Fool

a month ago

Warning: This Skyrocketing Stock Has a Hidden Risk

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
VKTX

Motley Fool

2 months ago

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
VKTX

Motley Fool

2 months ago

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

2 Disruptive Growth Stocks With Room to Run
VKTX

Motley Fool

2 months ago

2 Disruptive Growth Stocks With Room to Run

VKTX

MT Newswires

2 months ago

Piper Sandler Initiates Viking Therapeutics at Overweight

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
VKTX

Motley Fool

2 months ago

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment
VKTX

Investor's Business Daily

2 months ago

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
VKTX

MT Newswires

2 months ago

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment
VKTX

Investor's Business Daily

2 months ago

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
VKTX

Motley Fool

2 months ago

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

3 Monster Stocks in the Making
VKTX

Motley Fool

2 months ago

3 Monster Stocks in the Making

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
VKTX

Investor's Business Daily

2 months ago

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
VKTX

Zacks

2 months ago

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
VKTX

Zacks

2 months ago

VKTX Stock Loses Over $1B in a Month: How to Play the Stock?

VKTX

MT Newswires

2 months ago

B. Riley Initiates Viking Therapeutics at Buy With $109 Price Target

Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential?
VKTX

Insider Monkey

2 months ago

Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential?

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
VKTX

Benzinga

2 months ago

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

VKTX

MT Newswires

2 months ago

Viking Therapeutics Phase 2b Trial Into Non-Alcoholic Steatohepatitis Meets Primary, Secondary Endpoints

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
VKTX

PR Newswire

2 months ago

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

3 Things You Need to Know if You Buy Viking Therapeutics Today
VKTX

Motley Fool

2 months ago

3 Things You Need to Know if You Buy Viking Therapeutics Today

Is It Too Late to Buy Viking Therapeutics Stock?
VKTX

Motley Fool

2 months ago

Is It Too Late to Buy Viking Therapeutics Stock?

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
VKTX

Motley Fool

2 months ago

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
VKTX

Motley Fool

2 months ago

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
VKTX

Investor's Business Daily

2 months ago

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
VKTX

Motley Fool

2 months ago

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
VKTX

PR Newswire

2 months ago

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Is Viking Therapeutics a Buy on the Dip?
VKTX

Motley Fool

2 months ago

Is Viking Therapeutics a Buy on the Dip?

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
VKTX

Motley Fool

2 months ago

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
VKTX

Motley Fool

2 months ago

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

Viking Therapeutics Offers An Obesity Drug for Healthy Adults
VKTX

GuruFocus.com

3 months ago

Viking Therapeutics Offers An Obesity Drug for Healthy Adults

Viking stock fluctuates amid manufacturing concerns with obesity pill
VKTX

Clinical Trials Arena

3 months ago

Viking stock fluctuates amid manufacturing concerns with obesity pill

Is Viking Therepautics a Buy Now?
VKTX

Motley Fool

3 months ago

Is Viking Therepautics a Buy Now?

Why Viking Therapeutics Stock Plummeted After Soaring Today
VKTX

Motley Fool

3 months ago

Why Viking Therapeutics Stock Plummeted After Soaring Today

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat
VKTX

Investor's Business Daily

3 months ago

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

Viking Therapeutics stock falling amid results for new GLP-1 pill
VKTX

Yahoo Finance Video

3 months ago

Viking Therapeutics stock falling amid results for new GLP-1 pill

These Stocks Are Moving the Most Today: Nvidia, Intel, Apple, Sherwin-Williams, Talen, Constellation Energy, DJT, Peloton, and More
VKTX

Barrons.com

3 months ago

These Stocks Are Moving the Most Today: Nvidia, Intel, Apple, Sherwin-Williams, Talen, Constellation Energy, DJT, Peloton, and More

Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel
VKTX

The Wall Street Journal

3 months ago

Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results
VKTX

Investopedia

3 months ago

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results

A new weight loss pill outperformed Novo Nordisk's version
VKTX

Quartz

3 months ago

A new weight loss pill outperformed Novo Nordisk's version

Viking Therapeutics, Roblox, Trump Media: 3 Stocks In Focus
VKTX

Yahoo Finance Video

3 months ago

Viking Therapeutics, Roblox, Trump Media: 3 Stocks In Focus

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.
VKTX

Barrons.com

3 months ago

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

Viking Therapeutics Tops Novo Nordisk As Obesity Pill Brawl Continues
VKTX

Investor's Business Daily

3 months ago

Viking Therapeutics Tops Novo Nordisk As Obesity Pill Brawl Continues

VKTX

MT Newswires

3 months ago

Oppenheimer Adjusts Viking Therapeutics Price Target to $164 From $138, Maintains Outperform Rating

Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
VKTX

Benzinga

3 months ago

Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety

VKTX

MT Newswires

3 months ago

Viking Therapeutics Shares Advance Pre-Bell Amid New 'Positive' Data on VK2735 Studies

Nvidia to join Dow, election looms for Wall Street: Yahoo Finance
VKTX

Yahoo Finance Video

3 months ago

Nvidia to join Dow, election looms for Wall Street: Yahoo Finance

Big Pharma’s Obesity Bonanza Faces New Tests
VKTX

The Wall Street Journal

3 months ago

Big Pharma’s Obesity Bonanza Faces New Tests

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024
VKTX

PR Newswire

3 months ago

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024

Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data
VKTX

Investor's Business Daily

3 months ago

Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
VKTX

Investor's Business Daily

3 months ago

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

Viking Therapeutics to Participate at Upcoming Investor Conferences
VKTX

PR Newswire

3 months ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

Share on Social Networks: